5 Another study investigated the rate of excisional wound healing in diabetic rats treated with exendin-4, a GLP-1RA, and placebo
But what do we know about safety and how do patients know whether a drug that they're getting is safe
Regular monitoring should continue throughout treatment
All of our research peptides are produced under strict quality controls and are subjected to comprehensive third-party testing and batch analysis
In analysis of TTO based on parameter distributions and the valid cases, the median TTOs (Interquartile range) for SSIBs associated with semaglutide, liraglutide, dulaglutide, and exenatide were 15.5 (0.524.25, n = 18), 9.5 (0.561.5, n = 19), 35.5 (6.560.5, n = 11), and 2.5 (1.5169.5, n = 4) days, respectively (albiglutide was not included in the TTO analysis due to insufficient data)